Elanco Animal Health (NYSE:ELAN) Issues FY20 Earnings Guidance

Share on StockTwits

Elanco Animal Health (NYSE:ELAN) updated its FY20 earnings guidance on Wednesday. The company provided EPS guidance of $1.09-1.16 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.11. The company issued revenue guidance of $3.05-3.11 billion, compared to the consensus revenue estimate of $3.08 billion.Elanco Animal Health also updated its FY 2020
Pre-Market guidance to 1.09-1.16 EPS.

ELAN has been the subject of several analyst reports. Morgan Stanley upgraded Elanco Animal Health from an equal rating to an equal weight rating and cut their price target for the company from $34.00 to $32.00 in a report on Thursday, November 7th. Gabelli reiterated a buy rating on shares of Elanco Animal Health in a report on Tuesday, January 14th. UBS Group cut their price target on Elanco Animal Health from $30.00 to $28.00 and set a neutral rating for the company in a report on Wednesday, November 20th. Bank of America upgraded Elanco Animal Health from a neutral rating to a buy rating and set a $34.00 price target for the company in a report on Thursday, December 19th. Finally, Raymond James initiated coverage on Elanco Animal Health in a report on Thursday, January 9th. They issued a market perform rating for the company. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus target price of $33.83.

Shares of ELAN opened at $31.15 on Friday. The stock has a fifty day moving average of $30.54 and a two-hundred day moving average of $28.33. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.67 and a current ratio of 3.12. The company has a market capitalization of $11.28 billion, a PE ratio of 28.52, a price-to-earnings-growth ratio of 2.88 and a beta of 0.73. Elanco Animal Health has a fifty-two week low of $25.25 and a fifty-two week high of $35.46.

Elanco Animal Health (NYSE:ELAN) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.23 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.23. The company had revenue of $787.00 million during the quarter, compared to the consensus estimate of $790.83 million. Elanco Animal Health had a return on equity of 7.41% and a net margin of 2.21%. Elanco Animal Health’s revenue was down 1.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.29 EPS. As a group, equities research analysts forecast that Elanco Animal Health will post 1.12 earnings per share for the current fiscal year.

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals. The company offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and a range of food animal products used in ruminant and swine production.

Featured Article: How is diluted EPS different from basic EPS?

Earnings History and Estimates for Elanco Animal Health (NYSE:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.